Relevance of C-reactive protein levels in peritoneal dialysis patients

被引:47
|
作者
Fine, A [1 ]
机构
[1] Univ Manitoba, Nephrol Sect, Winnipeg, MB, Canada
关键词
cardiovascular disease; atherosclerosis; coronary artery disease; infection; chronic renal disease;
D O I
10.1046/j.1523-1755.2002.00145.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background. C-reactive protein (CRP) levels are increased in 30 to 50% of dialysis patients and predict cardiovascular morbidity and mortality. It is usually considered that raised CRP levels reflect underlying atherosclerosis. However, many patients may have clinically apparent cardiovascular disease without raised CRP levels. This study was designed to assess both the risk factors for high CRP levels and the usefulness of the test as a marker of clinically apparent coronary artery disease (CAD), peripheral vascular disease (PVD) and the presence of ongoing infections/inflammatory disorders (INF-INFL) in peritoneal dialysis patients. Methods. A chart review of 190 prevalent peritoneal dialysis patients was performed. CRP, albumin, ferritin, erythropoietin (EPO) dose and resistance, Kt/V, and residual renal function values were obtained and a history or presence of cardiovascular disease (CAD, PVD) and presence of INF-INFL recorded. Data were analyzed by Chi-square, Spearman correlation and logistic regression. Results. A total of 31% of patients had a raised CRP. INF-INFL was highly predictive of raised CRP levels (OR 16.97; 95% CI 5.41 to 53.14, P = 0.000), whereas CAD and PVD either singly or in combination had no such association. The sensitivity/specificity for CRP as a test for INF-INFL was 83/77%. For CAD and PVD, the sensitivities were less than 40% and specificities 70%. Increased CRP values were more common in females but not in diabetics. Weak linear correlations existed between CRP levels and albumin, ferritin and residual renal function (r = -0.212, 0.228 and -0.163 respectively P < 0.02). By regression analysis, INF-INFL predicted high CRP levels, but CAD and PVD did not. The majority of patients (57%) with high CRP had no identifiable cause; 40% of these patients had subsequent or previous normal CRP values. High transport status predicted high CRP levels (OR 7.28; 95% CI 1.417 to 37.36, P = 0.006). Conclusions. The majority of elevated CRP levels in peritoneal dialysis patients occur without an obvious cause. Clinically apparent cardiovascular disease does not predict high CRP levels. CRP levels vary over time in the same patient, from normal to high or vice versa, for no obvious reason. Sources of inflammation other than CAD, PVD and clinically obvious INF-INFL in peritoneal dialysis patients remain to be identified.
引用
收藏
页码:615 / 620
页数:6
相关论文
共 50 条
  • [1] Variability in C-reactive protein levels in hemodialysis and peritoneal dialysis patients
    Zemchenkov, Alexander
    Gerasimchuk, Roman
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 : 471 - 471
  • [2] MORTALITY AND PERITONITIS RISK STRATIFICATION IN PERITONEAL DIALYSIS PATIENTS: THE RELEVANCE OF C-REACTIVE PROTEIN
    Pinho, Ana
    Cabrita, Ana
    Guedes, Anabela Malho
    Fragoso, Andre
    Carreira, Helena
    Pinto, Isabel
    Bernardo, Idalecio
    Leao, Pedro
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 : 480 - 480
  • [3] C-reactive protein and cardiovascular disease in peritoneal dialysis patients
    Ducloux, D
    Bresson-Vautrin, C
    Kribs, M
    Abdelfatah, A
    Chalopin, JM
    KIDNEY INTERNATIONAL, 2002, 62 (04) : 1417 - 1422
  • [4] The effects of haemodialysis and peritoneal dialysis on serum lipoprotein(a) and C-reactive protein levels
    Borazan, A
    Üstün, H
    Yilmaz, A
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2003, 31 (05) : 378 - 383
  • [5] The effects of hemodialysis and peritoneal dialysis on serum homocysteine and C-reactive protein levels
    Borazan, A
    Aydemir, S
    Sert, M
    Yilmaz, A
    MEDIATORS OF INFLAMMATION, 2004, 13 (5-6) : 361 - 364
  • [6] Is C-reactive protein a useful predictor of outcome in peritoneal dialysis patients?
    Herzig, KA
    Purdie, DM
    Chang, W
    Brown, AM
    Hawley, CM
    Campbell, SB
    Sturtevant, JM
    Isbel, NM
    Nicol, DL
    Johnson, DW
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2001, 12 (04): : 814 - 821
  • [7] C-reactive protein and atherosclerosis in dialysis patients
    Zoccali, C
    Benedetto, FA
    Foca, A
    Tripepi, G
    Malatino, L
    Mallamaci, F
    Carla, LM
    Antonio, P
    Parlongo, S
    Cutrupi, S
    Marino, C
    Panuccio, V
    Postorina, M
    Candela, V
    Labare, C
    Tassone, F
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1998, 13 (10) : 2710 - 2711
  • [8] Evaluation of continuous ambulatory peritoneal dialysis fluid C-reactive protein in patients with peritonitis
    Ramanathan, Kumaresan
    Padmanabhan, Giri
    Vijayaraghavan, Bhooma
    SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2016, 27 (03) : 467 - 472
  • [9] Predictors of persistently elevated C-reactive protein (CRP) in peritoneal dialysis (pd) patients
    Garland, JS
    Chu, KH
    Moist, LM
    Heidenbeim, AP
    Blake, PB
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 595A - 595A
  • [10] Atorvastatin at conventional dose did not reduce C-reactive protein in patients on peritoneal dialysis
    Tse, Kai Chung
    Yung, Susan
    Tang, Colin Siu-On
    Tam, Sidney
    Lai, Kar Neng
    Chan, Tak Mao
    JOURNAL OF NEPHROLOGY, 2008, 21 (03) : 283 - 283